Tag - biontech

 
 

BIONTECH

Japan Times
WORLD / Science & Health
Dec 10, 2020
U.K. issues anaphylaxis warning on Pfizer vaccine after adverse reactions
Britain began mass vaccinating its population on Tuesday, part of a global drive that poses one of the biggest logistical challenges in peacetime history.
Japan Times
WORLD
Dec 6, 2020
With Pfizer's COVID-19 shot, Britain prepares for world-first vaccine rollout
Britain gave emergency use approval for the vaccine last week — jumping ahead in the global race to begin the most crucial mass inoculation program in history.
Japan Times
WORLD / Science & Health
Dec 3, 2020
Why the U.K. approved a COVID-19 vaccine first
Doses of the Pfizer-BioNTech vaccine will be injected starting next week, the government said.
Japan Times
COMMENTARY / World
Dec 1, 2020
A triumph of German innovation and immigration
The great advantage of BioNTech's approach is that it allows for the production of more than one billion vaccine doses within the space of just a few months.
Japan Times
WORLD / Science & Health
Nov 29, 2020
U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine
The U.K. is poised to become the first country to approve Pfizer Inc. and BioNTech SE’s COVID-19 vaccine, ahead of a long line of countries waiting for protection from the coronavirus.
Japan Times
COMMENTARY
Nov 22, 2020
Pfizer vaccine's safety milestone is just the beginning
As new vaccines look set for regulatory approval, managing the follow-up on adverse drug reactions will be critical for any vaccination program to be successful.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'
Final trial results showed the vaccine had a 95% success rate and no serious side effects, the drugmakers said.
Japan Times
WORLD / Science & Health / FOCUS
Nov 18, 2020
How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine
Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.
Japan Times
COMMENTARY / World
Nov 15, 2020
Here’s to the immigrant heroes behind the BioNTech vaccine
Their journey as Turkish Germans cannot have been easy. Discrimination, overt or subtle, is rife in German society.
Japan Times
COMMENTARY / World
Nov 13, 2020
What happens to the other COVID-19 vaccines now?
If the vaccine created by Pfizer and partner BioNTech fails to live up to its promise, will any slower but better competitors have a chance?
Japan Times
WORLD / Science & Health
Sep 16, 2020
Pfizer COVID-19 vaccine trial reports no major safety issues
Safety has been a paramount concern since AstraZeneca paused tests of the vaccine it's co-developing with the University of Oxford following an adverse event in a U.K.
Japan Times
BUSINESS / Companies
Jul 14, 2020
Pfizer and BioNTech coronavirus vaccine candidates on FDA fast track
The U.S.-listed shares of the German firm climbed about 15 percent, while Pfizer's stock rose about 5 percent.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?